Affordable Access

Genotoxic activity of four metabolites of the soy isoflavone daidzein

Authors
Journal
Mutation Research/Genetic Toxicology and Environmental Mutagenesis
1383-5718
Publisher
Elsevier
Publication Date
Volume
542
Identifiers
DOI: 10.1016/j.mrgentox.2003.08.003
Keywords
  • Phytoestrogens
  • Isoflavones
  • Micronuclei
Disciplines
  • Medicine

Abstract

Abstract Products containing phytoestrogens are increasingly promoted as the “natural” alternative to estrogen replacement therapy. In the present study, we have used the in vitro micronucleus assay in L5178Y mouse lymphoma cells to investigate the genotoxic potential of the isoflavone daidzein, and of four daidzein metabolites known to be formed in humans. Whereas no induction of micronuclei was observed with daidzein up to the limit of solubility (100 μM), all four daidzein metabolites, i.e. equol (2.3-fold induction at 100 μM), O-desmethylangolensin (6.2-fold induction at 10 μM), 4′,6,7-isoflavone (6.7-fold induction at 100 μM) and 3′,4′,7-isoflavone (8.2-fold induction at 100 μM) induced micronuclei in a concentration-dependent manner. Thus, both reductive and oxidative metabolites of the soy isoflavone daidzein exhibit genotoxic potential in vitro.

There are no comments yet on this publication. Be the first to share your thoughts.

Statistics

Seen <100 times
0 Comments

More articles like this

Genotoxic activity of four metabolites of the soy...

on Mutation Research/Fundamental... Dec 09, 2003

Lack of significant genotoxicity of purified soy i...

on American Journal of Clinical N... April 2003

Oxidative metabolism enhances the cytotoxic and ge...

on Molecular Nutrition & Food Res... June 2014

Metabolism of the soyabean isoflavone daidzein by...

on Biochemical Pharmacology Aug 28, 2006
More articles like this..